Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Fusobacteriota testing
- Fusobacteria phylum monitoring
- potential gut inflammation and colorectal association tracking
What is Fusobacteriota?
Fusobacteriota (formerly Fusobacteria) is a phylum of gram-negative anaerobes. Its most clinically studied member - Fusobacterium nucleatum - has been associated in research with colorectal cancer tissue and gut inflammation. Phylum-level tracking provides an initial signal. Detected by shotgun sequencing.
Why is Fusobacteriota important?
While Fusobacteriota is a minor phylum in most healthy adult guts, elevated levels or overgrowth of specific species like F. nucleatum has been studied in the context of gut inflammation, and has been identified in some colorectal tissue samples in research settings. Monitoring phylum abundance provides a broad initial indicator.
What insights will I get?
Your Fusobacteriota level indicates the relative abundance of this phylum in your gut. Discuss elevated levels with your care team, particularly in the context of other disruptive organism signals.
.svg)
.avif)
.avif)
